ATE183203T1 - Endothelin-antagonisten - Google Patents

Endothelin-antagonisten

Info

Publication number
ATE183203T1
ATE183203T1 AT91403118T AT91403118T ATE183203T1 AT E183203 T1 ATE183203 T1 AT E183203T1 AT 91403118 T AT91403118 T AT 91403118T AT 91403118 T AT91403118 T AT 91403118T AT E183203 T1 ATE183203 T1 AT E183203T1
Authority
AT
Austria
Prior art keywords
representing
residue
leucine
valine
image
Prior art date
Application number
AT91403118T
Other languages
English (en)
Inventor
Gilles Hamon
Eve Mahe
Dung Le-Nguyen
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Application granted granted Critical
Publication of ATE183203T1 publication Critical patent/ATE183203T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/57536Endothelin, vasoactive intestinal contractor [VIC]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Dental Preparations (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
AT91403118T 1990-11-21 1991-11-20 Endothelin-antagonisten ATE183203T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9014498A FR2669339B1 (fr) 1990-11-21 1990-11-21 Nouveaux derives peptidiques, procede de preparation et application a titre de medicaments de ces nouveaux derives.

Publications (1)

Publication Number Publication Date
ATE183203T1 true ATE183203T1 (de) 1999-08-15

Family

ID=9402414

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91403118T ATE183203T1 (de) 1990-11-21 1991-11-20 Endothelin-antagonisten

Country Status (10)

Country Link
US (1) US5510331A (de)
EP (1) EP0487410B1 (de)
JP (1) JP3373217B2 (de)
AT (1) ATE183203T1 (de)
CA (1) CA2055902A1 (de)
DE (1) DE69131518T2 (de)
DK (1) DK0487410T3 (de)
ES (1) ES2135389T3 (de)
FR (1) FR2669339B1 (de)
GR (1) GR3031331T3 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6087324A (en) 1993-06-24 2000-07-11 Takeda Chemical Industries, Ltd. Sustained-release preparation
WO1995000546A1 (fr) * 1993-06-25 1995-01-05 Kyowa Hakko Kogyo Co., Ltd. Peptide a effet antagoniste de l'endotheline
ATE178071T1 (de) * 1994-07-25 1999-04-15 Kyowa Hakko Kogyo Kk Endothelin-antagonisierendes peptid
DE60009883T2 (de) 1999-03-01 2005-04-07 Elan Pharmaceuticals, Inc., San Francisco Alpha-aminoessigsäure derivate als alpha 4 beta 7- rezeptor antagonisten

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE90108T1 (de) * 1987-10-09 1993-06-15 Takeda Chemical Industries Ltd Vasokonstriktor-peptid.
GB8913089D0 (en) * 1989-06-07 1989-07-26 Ciba Geigy Japan Ltd Novel endothelin derivative
WO1992002237A1 (en) * 1990-08-08 1992-02-20 The Rockefeller University Analogs of endothelin

Also Published As

Publication number Publication date
GR3031331T3 (en) 1999-12-31
DK0487410T3 (da) 2000-03-27
JP3373217B2 (ja) 2003-02-04
EP0487410A2 (de) 1992-05-27
DE69131518D1 (de) 1999-09-16
FR2669339A1 (fr) 1992-05-22
EP0487410A3 (en) 1992-09-30
US5510331A (en) 1996-04-23
CA2055902A1 (fr) 1992-05-22
FR2669339B1 (fr) 1995-03-03
EP0487410B1 (de) 1999-08-11
ES2135389T3 (es) 1999-11-01
JPH04283600A (ja) 1992-10-08
DE69131518T2 (de) 2000-01-13

Similar Documents

Publication Publication Date Title
NO923142D0 (no) Cykliske peptider og anvendelse derav
MY121908A (en) 3-amidopyrazole derivatives, process for preparing these and pharmaceutical compositions containing them.
WO2000012541A3 (en) Cytotoxic peptides modified by bulky or lipophilic moieties
DK0689592T3 (da) Stabile produkter af det baktericide/permeabilitetsforøgende protein og farmaceutiske sammensætninger, der indeholder disse
ATE121755T1 (de) Deletionsanaloga von magaininpeptiden.
DK539483D0 (da) Fremgangsmade til fremstilling af peptider
FR2647677B1 (fr) Nouvelles micro-proteines, procede de preparation et application a titre de medicaments de ces nouvelles micro-proteines
ES2081442T3 (es) Proteasa de bacillus licheniformis.
NO971621D0 (no) Keratinocyttvekstfaktoranaloger
ES2066510T3 (es) Nuevos polipeptidos con afinidad para lipopolisacaridos y sus usos.
ATE183203T1 (de) Endothelin-antagonisten
DK0556124T3 (da) Hidtil ukendte peptidderivater deres fremstilling og anvendelse som lægemidler
DE69104220D1 (de) Verfahren zur Herstellung von direktkomprimierten, Cephalosporansäure Derivate enthaltendenTabletten.
ATE124955T1 (de) Substrat-peptide.
ATE30919T1 (de) Magensekretion hemmende peptidderivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel.
DK0490383T3 (da) Peptider af HIV-gag-proteinet, fremstilling og anvendelse deraf
ES8502611A1 (es) Un procedimiento para preparar composiciones farmaceuticas a base de sales de teofilina y aminoacidos basicos

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee